Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Type 2 Diabetes

Interventions

DRUG

Roflumilast

Roflumilast tablets

DRUG

Alogliptin

Alogliptin tablets

DRUG

Exenatide

Exenatide solution

DRUG

Placebo to roflumilast

Placebo-matching roflumilast tablets

DRUG

Placebo to alogliptin

Placebo-matching alogliptin tablets

Trial Locations (2)

Chula Vista

Orlando